非典型的酸酶DUSP11抑制促进了nc886的表达,并通过NF-kB调制增强了gemcitabine介导的细胞死亡
Verena Silva Santos1, Gabriela Maciel Vieira1, Mariana Tannús Ruckert1
1Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Cancer gene therapy
|July 24, 2024
概括
在胰腺癌中,抑制DUSP11酸酶使得凝治疗更有效,因为它准NF-κB通路并增强癌细胞死亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种高度致命的癌症,治疗选择有限.
- 吉姆西塔 (Gem) 是一线治疗,但耐药性仍然是一个重大挑战.
- 了解信号反循环,特别是酸酶,对于克服阻力至关重要.
研究的目的:
- 确定涉及PDAC中gemcitabine反应的双特异性酸酶 (DUSP).
- 为了研究DUSP11在PDAC细胞中介导对gemcitabine耐药性的作用.
- 阐明DUSP11通过哪些分子机制影响宝石素敏感性.
主要方法:
- 基于CRISPR/Cas9的表型查,以确定相关的DUSP家族成员.
- 在体外实验中评估细胞存活率,细胞亡和细胞毒性在DUSP11抑制和凝胺治疗后.
- 在PDAC患者样本的in silico转录组分析 (RNA-seq).
- 西部斑点分析以评估蛋白质酸化和信号通路激活.
主要成果:
- 一个CRISPR屏幕确定了DUSP11作为PDAC中gemcitabine反应的关键调节器.
- DUSP11的遗传抑制使PDAC细胞对凝素敏感,增强细胞毒性和亡.
- 在PDAC患者数据中,DUSP11上调与NF-κB信号通路激活相关.
- DUSP11抑制阻断了凝胺诱导的NF-κB酸化,并通过nc886.6调节了PKR-NF-κB级联.
结论:
- DUSP11是一种关键的RNA酸酶,在胰腺癌中赋予耐 gemcitabine 的抗性.
- 抑制DUSP11代表了一种潜在的治疗策略,以改善PDAC中的凝丁疗效.
- 这项研究揭示了DUSP11在RNA生物学和癌症药物耐药性中的作用的新见解.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
10:26Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
5.6K
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K